Significance of the Study {#sec1_1}
=========================

• To investigate genotype-phenotype changes associated with SNPs of rs1801278 *(GABBR1)*, rs29230 *(IRS-1)*, and rs9902709 *(HCRT)* genes in Chinese Han individuals. This study revealed that the SNPs of rs1801278 and rs29230 were susceptible markers for the increasing risk of obstructive sleep hypoapnea syndrome, but rs9902709 did not appear to be a susceptibility locus.

Introduction {#sec1_2}
============

Obstructive sleep apnea hypopnea syndrome (OSAHS) is a common disorder characterized by the limitation of airflow resulting from repetitive episodes of partial or complete upper airway collapse during sleep \[[@B1]\]. These recurrent episodes usually lead to repetitive breathing pauses during sleep, accompanied by snoring, marked sleep fragmentation, transient hypoxia and hypercapnia, and chronic excessive daytime sleepiness \[[@B2]\]. While ventilation is normal in waking patients with OSAHS, sleep-related reductions in motoneuronal activity result in collapse of the upper airway. With changing lifestyles and dietary habits, the global prevalence of OSAHS has been determined to be fairly high, and is estimated to affect up to 17% of middle-aged men and 9% of middle-aged women \[[@B3]\].

The pathogenesis of OSAHS is not fully elucidated at the hereditary level. However, genetic and epidemiological studies indicate that OSAHS susceptibility is associated with multiple genetic, environmental, and developmental factors \[[@B4]\]. The pathophysiology of OSAHS may be investigated by detecting novel genetic susceptibility markers, which could lead to the development of new preventive and curative methods. Genetic variants increase the risk of OSAHS due to involvement in pathways of the upper airway anatomy, airway collapsibility, ventilation, and sleep-wake control \[[@B5]\].

An association between Ala20Val polymorphism and C/C variant of the *GABBR1* Phe658Phe polymorphism and OSAHS had been reported in Turkish individuals \[[@B6]\], but not for the genotype and allele frequencies of *IRS-1* rs1801278 \[[@B7]\]. In addition, also, an association between the C allele of the *HCRT* rs9902709 variation and OSAHS was reported in a Japanese population \[[@B8]\]. Hence based on these findings the objective of this study was to investigate genotype-phenotype changes between rs29230 in γ-aminobutyric acid B receptor *(GABBR1)*, rs1801278 in insulin receptor substrate-1 *(IRS-1)*, rs9902709 in hypocretin neuropeptide precursor *(HCRT)* and OSAHS in Chinese Han individuals.

Subjects and Methods {#sec1_3}
====================

Subjects {#sec2_1}
--------

A total of 130 Han patients with OSAHS (20 females and 110 males) and 136 controls (24 females and 112 males) who were examined at the Sleep Disorders Center of Zhejiang Hospital (Hangzhou, China) were enrolled in this study in southeast China (fig. [1](#F1){ref-type="fig"}). The subjects were divided into two subgroups based on body mass index (BMI). The patient cohort consisted of 116 overweight (BMI ≥25) and 14 normal-weight (BMI \<25) individuals, while the control group comprised 92 overweight and 44 normal-weight subjects. Each of them provided a written informed consent prior to being enrolled in the study. The research was conducted in accordance with the World Medical Association Declaration of Helsinki and approved by the Ethics Committee of Zhejiang Hospital.

OSAHS Diagnosis and Exclusion Criteria {#sec2_2}
--------------------------------------

Study participants underwent diagnostic overnight polysomnography (Alice LE; Philips Respironics Inc., Murrysville, Pa., USA). The baseline examination comprised pulsoxymetry, electrophysiological signals (electroencephalography, electro-oculography, and electromyography), electrocardiography, observation of thoracic movement and the analysis of sleep stages, snoring phases, and awakening reactions. Recordings were reviewed independently by two sleep specialists (J.D. and T.T.). Apnea was defined as the continuous cessation of airflow for \>10 s, and hypopnea as a ≥50% reduction in airflow for \>10 s with oxygen desaturation of ≥4%. The apnea-hypopnea index (AHI) was calculated as the total number of apnea and hypopnea events per hour of sleep. Patients were grouped according to OSAHS severity as follows: mild OSAHS (AHI 5--15 events/h), moderate OSAHS (AHI 16--30 events/h), and severe OSAHS (AHI \>30 events/h). The exclusion criteria were: hypothyroidism, acromegaly, micrognathia, central sleep apnea, rhinitis, nasal polyposis, tonsil hypertrophy, or cardiac insufficiency; chronic obstructive pulmonary disease or interstitial lung disease; a history of drug or alcohol abuse, and depression, and any kind of treatment for OSAHS. 129 subjects were excluded accordingly.

DNA Extraction and Genotyping {#sec2_3}
-----------------------------

Peripheral blood samples were obtained from each participant and stored at −70°C. The DNA was isolated from human peripheral leukocytes of whole-blood samples using the AxyPrep Blood Genomic DNA Miniprep Kit (Axygen Biosciences, Union City, Calif., USA). The single nucleotide polymorphisms (SNPs) *HCRT* rs9902709, *GABBR1* rs29230, and *IRS-1* rs1801278 were amplified using the GeneAmp PCR System 9700 (ABI Co. Ltd., New York, N.Y., USA). Primers for polymerase chain reaction (PCR) and single-base extension were designed using Assay Designers software version 3.0 (Sequenom Inc., San Diego, Calif., USA) and were processed following standard protocols for iPLEX chemistry. Primers were synthesized by Sangon Biotech Shanghai Co. Ltd. (Shanghai, China; table [1](#T1){ref-type="table"}).

Multiplex PCR was performed in 5-μl volumes containing 0.1 units of HotStar Taq polymerase (Qiagen, Hilden, Germany), 10 ng of whole genome-amplified genomic DNA, 2.5 pmol of each primer, and 2.5 μmol of dNTP. Thermocycling was carried out at 94°C for 15 min followed by 45 cycles of 94°C for 20 s, 56°C for 30 s, and 72°C for 1 min, with a final incubation at 72°C for 3 min. Unincorporated dNTPs were deactivated using 0.3 units of shrimp alkaline phosphatase (Sequenom Inc.). Primer extension was performed using 5.4 pmol of each primer extension probe, 50 μmol of the appropriate ddNTP combination, and 0.5 units of iPLEX enzyme (Sequenom Inc.). Extension reactions were carried out at 94°C for 15 min followed by 45 cycles at 94°C for 20 s, then 56°C for 30 s, and 72°C for 1 min, and a final incubation at 72°C for 3 min.

Thermocycling A cation exchange resin was used to remove residual salt from the reactions. Purified primer extension reaction products were spotted into a 384-well SpectroCHIP using the MassARRAY Nanodispenser (Sequenom Co.) and determined by a matrix-assisted laser desorption/ionization time-of-flight mass spectrometer. Genotype calling was performed in real time with MassARRAY RT software version 3.0.0.4 and analyzed using MassARRAY Typer software version 3.4.

Statistical Analysis {#sec2_4}
--------------------

Continuous values were expressed as means ± standard deviation. Hardy-Weinberg equilibrium testing was carried out for all three SNPs. Pearson\'s χ^2^ tests were used to compare the alleles and genotypes between cases and controls, and stratified analyses were performed to evaluate the difference of these SNPs among subgroups based on gender, BMI, and severity of disease. Odds ratios (ORs) and 95% confidence intervals (CIs) were obtained with Plink software (OpenLink Software Inc., Burlington, Mass., USA). p values \<0.05 were considered statistically significant.

Results {#sec1_4}
=======

Characteristics of Study Subjects {#sec2_5}
---------------------------------

Clinical and polysomnographic characteristics of study subjects are shown in table [2](#T2){ref-type="table"}. The mean age was 51.78 ± 12.24 years (range = 31--67) in cases and 50.88 ± 8.21 years (range = 31--60) in controls, Following BMI classification, 116 OSAHS patients (89.23%) had a higher likelihood of being overweight, while, by contrast, 44 healthy subjects (32.35%) with normal weight were more prevalent in the control group; the difference between the two groups was significant (p = 0.005). We examined Hardy-Weinberg equilibrium in the controls and cases with observed p values of 0.00212 for rs9902709, 0.86024 for rs1801278, and 0.85051 for rs29230.

Polymorphisms in Case and Control Cohorts {#sec2_6}
-----------------------------------------

For SNP rs29230, allele and genotype frequencies were 71.7% (T), 28.3% (C), 9.3% (CC), 50.4% (TT), and 40.3% (CT) in patients, and 83.8% (T), 16.2% (C), 69.9% (TT), and 30.1% (CT) in controls; differences were significant between the two groups (χ^2^ = 5.4914, p = 0.0191, OR = 0.493, 95% CI = 0.271--0.896, and χ^2^ = 7.7729, p = 0.0205), indicating that possession of the C allele is associated with susceptibility to OSAHS (table [3](#T3){ref-type="table"}). To further explore allele and genotype frequency differences, the subgroup analysis demonstrated that the allele and genotype distributions of rs29230 were 70.5% (T), 29.5% (C), 11.8% (CC), 51.8% (TT), and 36.4% (CT) in male patients, and 83.9% (T), 16.1% (C), 67.9% (TT), 32.1% (CT), and 0% (CC) in male controls, indicating that possession of at least one C allele is significantly more frequent in patients than controls (p = 0.0202, OR = 0.467, 95% CI = 0.243--0.895, and p = 0.0259; table [4](#T4){ref-type="table"}). However, no differences were identified between female patients and controls (table [4](#T4){ref-type="table"}). Likewise, the C allele of rs29230 was more prevalent in cases than controls in the overweight subgroup (p = 0.0333, OR = 0.487, 95% CI = 0.250--0.951; table [5](#T5){ref-type="table"}).

For rs1801278 variants, only the G allele was detected in cases, with A and G alleles present in controls; a significant difference was observed between cases and controls (χ^2^ = 3.8819, p = 0.0488; table [3](#T3){ref-type="table"}). Moreover, the GG genotype was significantly more common in patients than controls (χ^2^ = 3.9421, p = 0.0471; table [3](#T3){ref-type="table"}). However, subgroup analysis according to gender, BMI and severity of disease indicated that no significant associations with OSAHS risk were identified (tables [4](#T4){ref-type="table"}, [5](#T5){ref-type="table"}, [6](#T6){ref-type="table"}).

Allele and genotype frequencies of rs9902709 were 98.5% (A), 1.5% (G), 3.1% (AG), and 96.9% (AA) in cases, and 96.3% (A), 3.7% (G), 4.4% (AG), 94.1% (AA), and 1.5% (GG) in controls; the lack of significance between the two groups indicates that rs9902709 variants are not involved in the etiology of OSAHS (χ^2^ = 1.1857, p = 0.2762, OR = 2.443, 95% CI = 0.465--12.82, and χ^2^ = 1.1408, p = 0.5653; table [3](#T3){ref-type="table"}). Furthermore, stratified analysis according to gender, BMI, and severity of disease also revealed no associations with OSAHS (tables [4](#T4){ref-type="table"}, [5](#T5){ref-type="table"}, [6](#T6){ref-type="table"}).

Discussion {#sec1_5}
==========

The present study showed that the SNPs *GABBR1* rs29230 and *IRS-1* rs1801278 were susceptibility candidates for OSAHS in Chinese Han individuals. However, no association between *HCRT* rs9902709 and OSAHS was revealed.

The patency of the upper airway during respiration is controlled mostly by muscle activity, which also prevents collapse due to negative airway pressure \[[@B9]\]. Hypoglossal motoneurons are cholinergic elements that innervate tongue muscles and play important roles during respiration. Dysfunction of the hypoglossal motoneurons appears to be implicated in OSAHS \[[@B10]\]. The hypoglossal motor nucleus releases GABA, which has an important physiological function through its association with a large family of receptors, including the metabotropic GABA~B~ receptor \[[@B11]\]. This is encoded by *GABBR1*, which maps to chromosome 6, contains 22 exons, and spans at least 18 kb \[[@B12],[@B13]\]. It is therefore conceivable that *GABBR1* variations correlate with the etiology of OSAHS.

Our present study showed significant differences in *GABBR1* SNP rs29230 between OSAHS cases and controls (p = 0.0205), especially in male and overweight patients, which was concordant with those reports. The previous research by Bayazit et al. \[[@B6]\] showed that *GABBR1* polymorphisms are associated with the occurrence of OSAHS in the Turkish population. However, the overweight individuals in OSAHS patients were more prevalent than healthy controls, which may increase the possibility of obtaining spurious findings because an increased body weight can cause the development of OSAHS. Nevertheless, our findings and previous studies indicate that *GABBR1* is a susceptibility locus for OSAHS, independently of ethnic background and environmental agents.

Our present study also identified a strong association between the *IRS-1* rs1801278 G allele or GG genotype and an increased risk of developing OSAHS in the Chinese Han population. To the best of our knowledge, the association between OSAHS and type 2 diabetes mellitus and insulin resistance is independent of obesity \[[@B14]\]. The IRS is the main substrate of insulin receptor tyrosine kinase, and represents a key element in the actions of insulin and insulin-like growth factor. The IRS family consists of 4 closely related members, and *IRS-1* on chromosome 2q has been regarded as a plausible susceptibility locus for insulin resistance in type 2 diabetes mellitus. Among the known *IRS-1* polymorphisms, associations were previously observed with diabetes mellitus, cancer, multiple myeloma, and Alzheimer\'s disease \[[@B15],[@B16],[@B17],[@B18]\]. However, Bayazit et al. \[[@B6]\] reported no significant differences in the genotype and allele frequencies of *IRS-1* rs1801278 between OSAHS patients and controls overall, but *IRS-1* variants in male Turkish patients appeared to be susceptible to OSAHS development via a gender-specific comparison \[[@B7]\], which was inconsistent with our finding. The discrepancy between our results and the previous study could be attributed to ethnic or environmental factors, so further studies are needed to verify the findings.

Additionally, the current research demonstrated that no association between rs9902709 variants and OSAHS was identified in Chinese Han individuals. Based on our results, it seems reasonable to speculate that *HCRT* variants are not involved in the development of OSAHS. The previous study reported that circulating hypocretin levels were significantly lower in OSAHS patients than controls, and inversely correlated with the severity of OSAHS \[[@B19],[@B20]\]; however, a clinical trial by Ahmed et al. \[[@B8]\] had previously found that the frequency of the *HCRT* rs9902709 variation increased *HCRT* expression, and was associated with a decreased risk for OSAHS in the Japanese population. These differences between the two studies may be primarily attributed to environmental factors which have the potential to interact with the genetic background.

The present study had two limitations: the sample size was relatively small and OSAHS patients were more likely to be overweight than controls, which might have increased the chance of obtaining spurious findings. Future analysis should investigate a larger sample size, and include these risk factors.

Conclusion {#sec1_6}
==========

The present study showed that SNPs rs1801278 and rs29230 were associated with an increased risk of OSAHS, and that *HCRT* did not appear to be a susceptibility gene for OSAHS.
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====================
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###### 

Oligonucleotide sequences used for genotyping

  ---------------------------------------------------------------------------------------------------------------
  Gene       SNP                Allele/Primers     Sequences
  ---------- ------------------ ------------------ --------------------------------------------------------------
  *IRS-1*    rs1801278\         Allele\            ATGGGCAGACTGGGCCCTGCACCTCCC\[G/A\]GGG-CTGCTAGCATTTGCAGGCCTA\
             *(Homo sapiens)*   First primer\      5′-ACGTTGGATGATGGTCATGTAGTCACCCCG-3′\
                                Second primer\     5′-ACGTTGGATGGTCGAGATGGGCAGACTGG-3′\
                                Extension primer   5′-AAATGCTAGCAGCCC-3′

                                                   

  *GABBR1*   rs29230\           Allele\            ATGGTTACCACATTGGGAGGAACCAG\[T/C\]CCTTTCGTCTGCCAGGTGAGGAGG\
             *(Homo sapiens)*   First primer\      5′-ACGTTGGATGTCGATGGTTACCACATTGGG-3′\
                                Second primer\     5′-ACGTTGGATGCCTGTAAGGAATTTGCCCAC-3′\
                                Extension primer   5′-TGGGAGGAACCAGTT-3′

                                                   

  *HCRT*     rs9902709\         Allele\            CTCTGGGATGGTGAGTCACCCCTCC\[A/G\]TC-CCTGGATCTTTACCTTTGTGGAA\
             *(Homo sapiens)*   First primer\      5′-ACGTTGGATGGCCAGACACCATGAACCTTC-3′\
                                Second primer\     5′-ACGTTGGATGTTTGCTTCTCTGGGATGGTG-3′\
                                Extension primer   5′-GGAAAGGTAAAGATCCAGGGA-3′
  ---------------------------------------------------------------------------------------------------------------

###### 

Clinical and polysomnographic characteristics of the study subjects

  Variables                        Patients        Controls        p value
  -------------------------------- --------------- --------------- ---------
  *Demographics*                                                   
  Gender, n                                                        0.817
   Male                            110 (84.6%)     112 (82.4%)     
   Female                          20 (15.4%)      24 (17.6%)      
  Mean age ± SD, years             51.78 ± 12.24   50.88 ± 8.21    0.617
  Mean BMI ± SD                    28.17 ± 3.62    25.38 ± 3.17    
  Normal weight, n                 14 (10.77%)     44 (32.35%)     0.005
  Overweight, n                    116 (89.23%)    92 (67.65%)     
  Severity of disease, n                                           \<0.001
   Normal                          0               136             
   Mild                            26 (20%)        UN              
   Moderate                        22 (16.92%)     UN              
   Severe                          82 (63.08%)     UN              
                                                                   
  *Polysomnography (means ± SD)*                                   
  AHI, events/h                    35.66 ± 19.52   3.43 ± 1.12     \<0.001
   Male                            38.78 ± 18.16   3.32 ± 2.05     
   Female                          25.76 ± 15.13   3.12 ± 1.07     
   Overweight                      39.12 ± 22.32   4.09 ± 1.87     
   Normal weight                   28.34 ± 13.32   2.89 ± 0.97     
  MAI, events/h                    26.28 ± 16.09   4.87 ± 1.56     \<0.001
  LSaO~2~, %                       74.27 ± 11.15   96.85 ± 3.8     \<0.001
  ODI4, events/h                   43.42 ± 25.17   4.16 ± 1.08     
  Sleep stages, % of TST                                           
   NREM1                           54.21 ± 18.79   47.9 ± 20.04    \<0.001
   NREM2                           99.73 ± 32.31   92.1 ± 36.21    \<0.001
   NREM3/4                         60.51 ± 19.95   46.23 ± 15.72   \<0.001
   REM                             53.23 ± 18.31   39.74 ± 16.36   \<0.001

LSaO~2~ = Lowest oxygen saturation; MAI = microarousal index; NREM = non-rapid eye movement sleep; ODI4 = oxygen desaturation index; REM = rapid eye movement sleep; SD = standard deviation; TST = total sleep time; UN = unknown.

###### 

Allele and genotype distribution in the patients and controls

  Gene                Cases         Controls      χ^2^     p value   OR (95% CI)
  ------------------- ------------- ------------- -------- --------- -----------------------
  *HCRT* rs9902709                                                   
  Allele                                          1.1857   0.2762    
   A                  255 (0.981)   260 (0.942)                      
   G                  5 (0.019)     16 (0.058)                       2.443 (0.465--12.820)
  Genotype                                        1.1408   0.5653    
   AG                 5 (0.038)     6 (0.044)                        
   AA                 125 (0.962)   128 (0.941)                      
   GG                 0 (0.000)     2 (0.015)                        
                                                                     
  *GABBR1* rs29230                                                   
  Allele                                          5.4914   0.0191    
   T                  185 (0.717)   228 (0.838)                      
   C                  73 (0.283)    44 (0.162)                       0.493 (0.271--0.896)
  Genotype                                        7.7729   0.0205    
   CC                 12 (0.093)    0 (0.000)                        
   TT                 65 (0.504)    95 (0.699)                       
   CT                 52 (0.403)    41 (0.301)                       
                                                                     
  *IRS-1* rs1801278                                                  
  Allele                                          3.8819   0.0488    
   A                  0 (0.000)     9 (0.033)                        
   G                  260 (1.000)   263 (0.967)                      
  Genotype                                        3.9421   0.0471    
   AG                 0 (0.000)     9 (0.067)                        
   GG                 130 (1.000)   127 (0.933)                      

###### 

Allele and genotype distribution in the patients and controls both according to gender

  ---------------------------------------------------------------------------------------------------------------------------------------------
  Gene                Male          p value       OR\        Female                 controls     p value      OR\        
                                                  (95% CI)                                                    (95% CI)   
  ------------------- ------------- ------------- ---------- ---------------------- ------------ ------------ ---------- ----------------------
  *HCRT* rs9902709                                                                                                       

  Allele                                                                                                                 

   A                  215 (0.977)   215 (0.960)                                     40 (1.000)   45 (0.938)              

   G                  5 (0.023)     9 (0.040)     0.4206     2 (0.359--11.149)      0 (0.000)    3 (0.062)    0.3558     

  Genotype                                                                                                               

   AG                 5 (0.045)     5 (0.044)                                       0 (0.000)    2 (0.083)               

  AA                  105 (0.955)   105 (0.938)                                     20 (1.000)   22 (0.917)   0.3501     

   GG                 0 (0.000)     2 (0.018)     0.6092                                                                 

                                                                                                                         

  *GABBR1* rs29230                                                                                                       

  Allele                                                                                                                 

  T                   155 (0.705)   188 (0.839)                                     27 (0.750)   40 (0.833)              

  C                   65 (0.295)    36 (0.161)    0.0202     0.467 (0.243--0.895)   9 (0.250)    8 (0.167)    0.650      0.7 (0.149--3.282)

  Genotype                                                                                                               

   CC                 13 (0.118)    0 (0.000)                                                                            

   TT                 57 (0.518)    76 (0.679)                                      10 (0.556)   15 (0.625)              

   CT                 40 (0.364)    36 (0.321)    0.0259                            8 (0.444)    9 (0.375)    0.6039     0.625 (0.105--3.707)

                                                                                                                         

  *IRS-1* rs1801278                                                                                                      

  Allele                                                                                                                 

   A                  0 (0.000)     5 (0.022)                                       0 (0.000)    3 (0.063)               

   G                  220 (1.000)   219 (0.978)   0.0839                            40 (1.000)   45 (0.937)   0.3558     

  Genotype                                                                                                               

   AG                 0 (0.000)     5 (0.045)                                       0 (0.000)    2 (0.083)               

   GG                 110 (1.000)   107 (0.955)   0.0818                            20 (1.000)   22 (0.917)   0.3501     
  ---------------------------------------------------------------------------------------------------------------------------------------------

###### 

Allele and genotype distribution in the patients and controls according to BMI

  --------------------------------------------------------------------------------------------------------------------------------------
  Gene       Normal weight   p value      OR\        Overweight              p value       OR\                    
                                          (95% CI)                                         (95% CI)               
  ---------- --------------- ------------ ---------- ----------------------- ------------- ------------- -------- ----------------------
  *HCRT*     rs9902709                                                                                            

  Allele                                                                                                          

   A         28 (1.000)      82 (0.976)                                      227 (0.978)   175 (0.951)            

   G         0 (0.000)       2 (0.024)    0.5602     3.029 (0.737--12.455)   5 (0.022)     9 (0.049)     0.2615   2.591 (0.464--14.47)

  Genotype                                                                                                        

   AG        0 (0.000)       2 (0.048)                                       5 (0.043)     5 (0.054)              

   AA        14 (1.000)      40 (0.952)   0.5566                             111 (0.957)   85 (0.924)             

   GG                                                                        0 (0.000)     2 (0.022)     0.5116   

                                                                                                                  

  *GABBR1*   rs29230                                                                                              

  Allele                                                                                                          

   T         23 (0.958)      72 (0.857)                                      165 (0.711)   155 (0.842)            

   C         1 (0.042)       12 (0.143)   0.5882     1.833 (0.199--16.916)   67 (0.289)    29 (0.158)    0.0333   0.487 (0.250--0.951)

  Genotype                                                                                                        

   TT        10 (0.833)      30 (0.714)                                      58 (0.500)    60 (0.652)             

   CT        0               0                                               45 (0.388)    32 (0.348)             

   CC        2 (0.167)       12 (0.286)   0.5573     2.000 (0.191--20.899)   13 (0.112)    0 (0.000)     0.0506   

                                                                                                                  

  *IRS-1*    rs1801278                                                                                            

  Allele                                                                                                          

   A         0 (0.000)       4 (0.048)                                       0 (0.000)     4 (0.022)              

   G         28 (1.000)      80 (0.952)   0.4057                             232 (1.000)   180 (0.978)   0.1106   

  Genotype                                                                                                        

   AG        0 (0.000)       5 (0.119)                                       0 (0.000)     4 (0.043)              

   GG        14 (1.000)      37 (0.881)   0.3968                             116 (1.000)   88 (0.957)    0.1088   
  --------------------------------------------------------------------------------------------------------------------------------------

###### 

Allele and genotype distribution in OSAHS according to severity of disease

  Gene       OSAHS        p value      OR (95% CI)   OSAHS            p value      OR (95% CI)   OSAHS    p value          OR (95% CI)                          
  ---------- ------------ ------------ ------------- ---------------- ------------ ------------- -------- ---------------- ------------- ------------- -------- ----------------
  *HCRT*     rs9902709                                                                                                                                          
  Allele                                                                                                                                                        
   A         52 (1.000)   44 (1.000)                                  52 (1.000)   159 (0.970)                             44 (1.000)    159 (0.970)            
   G         0 (0.000)    0 (0.000)                                   0 (0.000)    5 (0.030)     0.4215                    0 (0.000)     5 (0.030)     0.4595   
  Genotype                                                                                                                                                      
   AG        0 (0.000)    0 (0.000)                                   0 (0.000)    5 (0.061)                               0 (0.000)     5 (0.061)              
   AA        26 (1.000)   22 (1.000)                                  26 (1.000)   77 (0.939)    0.4171                    22 (1.000)    77 (0.939)    0.4551   
                                                                                                                                                                
  *GABBR1*   rs29230                                                                                                                                            
  Allele                                                                                                                                                        
  T          45 (0.865)   31 (0.705)                                  45 (0.865)   105 (0.675)                             31 (0.705)    105 (0.675)            
  C          7 (0.135)    13 (0.295)   0.3123        2.063            7 (0.135)    55 (0.325)    0.0924   2.648            13 (0.295)    55 (0.325)    0.6398   1.284
                                                     (0.499--8.530)                                       (0.827--8.478)                                        (0.450--3.663)
  Genotype                                                                                                                                                      
   CC        2 (0.077)    2 (0.091)                                   2 (0.077)    6 (0.075)                               2 (0.091)     6 (0.075)              
   TT        20 (0.769)   15 (0.682)                                  20 (0.769)   35 (0.438)                              15 (0.682)    35 (0.438)             
   CT        4 (0.154)    5 (0.227)    0.7044                         4 (0.154)    39 (0.487)    0.0775                    5 (0.227)     39 (0.487)    0.146    
                                                                                                                                                                
  *IRS-1*    rs1801278                                                                                                                                          
  Allele                                                                                                                                                        
   G         52 (1.000)   44 (1.000)                                  52 (1.000)   164 (1.000)                             44 (1.000)    164 (1.000)            
  Genotype                                                                                                                                                      
   GG        26 (1.000)   22 (1.000)                                  26 (1.000)   82 (1.000)                              22 (1.000)    82 (1.000)             
